These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Steroids, interferon-alpha and ribavirin treatment of cryoglobulinemic glomerulonephritis concurrent with HCV infection]. Guarnieri A, Marazzi F, Giorgi MP, Canepari G, Pino C, Moggia E, Manca A, Ghezzi PM. G Ital Nefrol; 2002; 19(1):79-81. PubMed ID: 12165950 [Abstract] [Full Text] [Related]
3. Interferon and ribavirin combination therapy in patients with chronic hepatitis C and mixed cryoglobulinemia. Donada C, Crucitti A, Donadon V, Chemello L, Alberti A. Blood; 1998 Oct 15; 92(8):2983-4. PubMed ID: 9763592 [No Abstract] [Full Text] [Related]
12. A potent antiviral effect on hepatitis C viral dynamics in serum and peripheral blood mononuclear cells during combination therapy with high-dose daily interferon alfa plus ribavirin and intravenous twice-daily treatment with interferon beta. Asahina Y, Izumi N, Uchihara M, Noguchi O, Tsuchiya K, Hamano K, Kanazawa N, Itakura J, Miyake S, Sakai T. Hepatology; 2001 Aug 07; 34(2):377-84. PubMed ID: 11481623 [Abstract] [Full Text] [Related]
13. [Treatment of chronic hepatitis C]. Fehér J, Lengyel G. Orv Hetil; 2004 May 16; 145(20):1065-7. PubMed ID: 15202329 [No Abstract] [Full Text] [Related]
14. Antiviral therapy for cryoglobulinemic neuropathy: comment on the article by Saadoun et al. Gemignani F, Brindani F, Marbini A. Arthritis Rheum; 2007 Aug 16; 56(8):2810; author reply 2810-1. PubMed ID: 17665398 [No Abstract] [Full Text] [Related]
15. Triple antiviral therapy in hepatitis C virus infection with or without mixed cryoglobulinaemia: a prospective, controlled pilot study. Gragnani L, Fabbrizzi A, Triboli E, Urraro T, Boldrini B, Fognani E, Piluso A, Caini P, Ranieri J, Monti M, Laffi G, Zignego AL. Dig Liver Dis; 2014 Sep 16; 46(9):833-7. PubMed ID: 24953206 [Abstract] [Full Text] [Related]
16. Relapse of hepatitis C virus-associated mixed cryoglobulinemia vasculitis in patients with sustained viral response. Landau DA, Saadoun D, Halfon P, Martinot-Peignoux M, Marcellin P, Fois E, Cacoub P. Arthritis Rheum; 2008 Feb 16; 58(2):604-11. PubMed ID: 18240235 [Abstract] [Full Text] [Related]
17. Correlation of clinical and virologic responses to antiviral treatment and regulatory T cell evolution in patients with hepatitis C virus-induced mixed cryoglobulinemia vasculitis. Landau DA, Rosenzwajg M, Saadoun D, Trébeden-Negre H, Klatzmann D, Cacoub P. Arthritis Rheum; 2008 Sep 16; 58(9):2897-907. PubMed ID: 18759287 [Abstract] [Full Text] [Related]
18. Undetectable hepatitis C virus RNA at week 4 as predictor of sustained virological response in HIV patients with chronic hepatitis C. Martin-Carbonero L, Nuñez M, Mariño A, Alcocer F, Bonet L, García-Samaniego J, López-Serrano P, Cordero M, Portu J, Soriano V. AIDS; 2008 Jan 02; 22(1):15-21. PubMed ID: 18090387 [Abstract] [Full Text] [Related]
19. Rapid suppression of hepatitis C viremia induced by intravenous silibinin plus ribavirin. Biermer M, Berg T. Gastroenterology; 2009 Jul 02; 137(1):390-1. PubMed ID: 19486953 [No Abstract] [Full Text] [Related]
20. [The effect of cryoglobulinemia on the antiviral therapy in patients with chronic hepatitis C]. Fan XH, Wang LF, Liu LC, Yao Y, Shan Y, Lu HY, Wu CH, Xu XY, Wei L. Zhonghua Gan Zang Bing Za Zhi; 2011 Oct 02; 19(10):721-5. PubMed ID: 22409840 [Abstract] [Full Text] [Related] Page: [Next] [New Search]